User: Guest

MIRNA

Global Market Trajectory & Analytics

MCP13362

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

2994
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

539
Interactions with Platform & by Email

PARTICIPANTS

92
Unique # Participated

VALIDATIONS

41
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

159

PAGES

231

EDITION

9

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for microRNA (miRNA) estimated at US$220.4 Million in the year 2020, is projected to reach a revised size of US$712.9 Million by 2027, growing at aCAGR of 18.3% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 16.1% CAGR and reach US$357.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 20.8% CAGR for the next 7-year period.
The microRNA (miRNA) market in the U.S. is estimated at US$65.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$123.9 Million by the year 2027 trailing a CAGR of 17.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.5% and 15.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.We bring years of research experience to this 9th edition of our report. The 231-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abcam PLC; Agilent Technologies, Inc.; Bioline GmbH; Bio-Rad Laboratories, Inc.; BioVendor - Laboratorni medicina a.s; Dharmacon, Inc.; F. Hoffmann-La Roche AG; GeneCopoeia, Inc.; HTG Molecular Diagnostics, Inc.; Illumina, Inc.; Kaneka Eurogentec SA; MilliporeSigma; Miltenyi Biotec GmbH; Nanostring Technologies, Inc.; New England Biolabs, Inc.; Promega Corporation; Qiagen NV; Rosetta Genomics Ltd.; System Biosciences, Inc.; Thermo Fisher Scientific, Inc.
» Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications) » End-Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other End-Uses) » Type (Products, Services)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
microRNA (miRNA) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
microRNA (miRNA) Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
microRNA (miRNA) Global Retrospective Market Scenario in US$ by Region/Country: 2012-2019
microRNA (miRNA) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Products (Type) World Market by Region/Country in US$: 2020 to 2027
Products (Type) Historic Market Analysis by Region/Country in US$: 2012 to 2019
Products (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Services (Type) Potential Growth Markets Worldwide in US$: 2020 to 2027
Services (Type) Historic Market Perspective by Region/Country in US$: 2012 to 2019
Services (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Cancer (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027
Cancer (Application) Retrospective Demand Analysis in US$ by Region/Country: 2012-2019
Cancer (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Infectious Diseases (Application) Demand Potential Worldwide in US$ by Region/Country: 2020-2027
Infectious Diseases (Application) Historic Sales Analysis in US$ by Region/Country: 2012-2019
Infectious Diseases (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
Immunological Disorder (Application) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
Immunological Disorder (Application) Global Historic Analysis in US$ by Region/Country: 2012-2019
Immunological Disorder (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
Cardiovascular Disease (Application) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027
Cardiovascular Disease (Application) Analysis of Historic Sales in US$ by Region/Country for the Years 2012 to 2019
Cardiovascular Disease (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
Neurological Disease (Application) Global Opportunity Assessment in US$ by Region/Country: 2020-2027
Neurological Disease (Application) Historic Sales Analysis in US$ by Region/Country: 2012-2019
Neurological Disease (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
Other Applications (Application) Worldwide Sales in US$ by Region/Country: 2020-2027
Other Applications (Application) Historic Demand Patterns in US$ by Region/Country: 2012-2019
Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
Biotechnology & Pharmaceutical Companies (End-Use) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027
Biotechnology & Pharmaceutical Companies (End-Use) Retrospective Demand Analysis in US$ by Region/Country: 2012-2019
Biotechnology & Pharmaceutical Companies (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Academic & Government Research Institutes (End-Use) Demand Potential Worldwide in US$ by Region/Country: 2020-2027
Academic & Government Research Institutes (End-Use) Historic Sales Analysis in US$ by Region/Country: 2012-2019
Academic & Government Research Institutes (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
Other End-Uses (End-Use) Global Historic Analysis in US$ by Region/Country: 2012-2019
Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US miRNA Market Share (in %) by Company: 2019 & 2025
United States microRNA (miRNA) Market Estimates and Projections in US$ by Type: 2020 to 2027
microRNA (miRNA) Market in the United States by Type: A Historic Review in US$ for 2012-2019
United States microRNA (miRNA) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
United States microRNA (miRNA) Latent Demand Forecasts in US$ by Application: 2020 to 2027
microRNA (miRNA) Historic Demand Patterns in the United States by Application in US$ for 2012-2019
microRNA (miRNA) Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
United States microRNA (miRNA) Latent Demand Forecasts in US$ by End-Use: 2020 to 2027
microRNA (miRNA) Historic Demand Patterns in the United States by End-Use in US$ for 2012-2019
microRNA (miRNA) Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
Canadian microRNA (miRNA) Market Estimates and Forecasts in US$ by Type: 2020 to 2027
Canadian microRNA (miRNA) Historic Market Review by Type in US$: 2012-2019
microRNA (miRNA) Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
Canadian microRNA (miRNA) Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
microRNA (miRNA) Market in Canada: Summarization of Historic Demand Patterns in US$ by Application for 2012-2019
Canadian microRNA (miRNA) Market Share Analysis by Application: 2012 VS 2020 VS 2027
Canadian microRNA (miRNA) Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
microRNA (miRNA) Market in Canada: Summarization of Historic Demand Patterns in US$ by End-Use for 2012-2019
Canadian microRNA (miRNA) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
Japanese Market for microRNA (miRNA): Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
microRNA (miRNA) Market in Japan: Historic Sales Analysis in US$ by Type for the Period 2012-2019
Japanese microRNA (miRNA) Market Share Analysis by Type: 2012 VS 2020 VS 2027
Japanese Demand Estimates and Forecasts for microRNA (miRNA) in US$ by Application: 2020 to 2027
Japanese microRNA (miRNA) Market in US$ by Application: 2012-2019
microRNA (miRNA) Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
Japanese Demand Estimates and Forecasts for microRNA (miRNA) in US$ by End-Use: 2020 to 2027
Japanese microRNA (miRNA) Market in US$ by End-Use: 2012-2019
microRNA (miRNA) Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
Chinese microRNA (miRNA) Market Growth Prospects in US$ by Type for the Period 2020-2027
microRNA (miRNA) Historic Market Analysis in China in US$ by Type: 2012-2019
Chinese microRNA (miRNA) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Chinese Demand for microRNA (miRNA) in US$ by Application: 2020 to 2027
microRNA (miRNA) Market Review in China in US$ by Application: 2012-2019
Chinese microRNA (miRNA) Market Share Breakdown by Application: 2012 VS 2020 VS 2027
Chinese Demand for microRNA (miRNA) in US$ by End-Use: 2020 to 2027
microRNA (miRNA) Market Review in China in US$ by End-Use: 2012-2019
Chinese microRNA (miRNA) Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European miRNA Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European microRNA (miRNA) Market Demand Scenario in US$ by Region/Country: 2020-2027
microRNA (miRNA) Market in Europe: A Historic Market Perspective in US$ by Region/Country for the Period 2012-2019
European microRNA (miRNA) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European microRNA (miRNA) Market Estimates and Forecasts in US$ by Type: 2020-2027
microRNA (miRNA) Market in Europe in US$ by Type: A Historic Review for the Period 2012-2019
European microRNA (miRNA) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
European microRNA (miRNA) Addressable Market Opportunity in US$ by Application: 2020-2027
microRNA (miRNA) Market in Europe: Summarization of Historic Demand in US$ by Application for the Period 2012-2019
European microRNA (miRNA) Market Share Analysis by Application: 2012 VS 2020 VS 2027
European microRNA (miRNA) Addressable Market Opportunity in US$ by End-Use: 2020-2027
microRNA (miRNA) Market in Europe: Summarization of Historic Demand in US$ by End-Use for the Period 2012-2019
European microRNA (miRNA) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
microRNA (miRNA) Market in France by Type: Estimates and Projections in US$ for the Period 2020-2027
French microRNA (miRNA) Historic Market Scenario in US$ by Type: 2012-2019
French microRNA (miRNA) Market Share Analysis by Type: 2012 VS 2020 VS 2027
microRNA (miRNA) Quantitative Demand Analysis in France in US$ by Application: 2020-2027
French microRNA (miRNA) Historic Market Review in US$ by Application: 2012-2019
French microRNA (miRNA) Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
microRNA (miRNA) Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027
French microRNA (miRNA) Historic Market Review in US$ by End-Use: 2012-2019
French microRNA (miRNA) Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
microRNA (miRNA) Market in Germany: Recent Past, Current and Future Analysis in US$ by Type for the Period 2020-2027
German microRNA (miRNA) Historic Market Analysis in US$ by Type: 2012-2019
German microRNA (miRNA) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
microRNA (miRNA) Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2020-2027
German microRNA (miRNA) Market in Retrospect in US$ by Application: 2012-2019
microRNA (miRNA) Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
microRNA (miRNA) Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027
German microRNA (miRNA) Market in Retrospect in US$ by End-Use: 2012-2019
microRNA (miRNA) Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
Italian microRNA (miRNA) Market Growth Prospects in US$ by Type for the Period 2020-2027
microRNA (miRNA) Historic Market Analysis in Italy in US$ by Type: 2012-2019
Italian microRNA (miRNA) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Italian Demand for microRNA (miRNA) in US$ by Application: 2020 to 2027
microRNA (miRNA) Market Review in Italy in US$ by Application: 2012-2019
Italian microRNA (miRNA) Market Share Breakdown by Application: 2012 VS 2020 VS 2027
Italian Demand for microRNA (miRNA) in US$ by End-Use: 2020 to 2027
microRNA (miRNA) Market Review in Italy in US$ by End-Use: 2012-2019
Italian microRNA (miRNA) Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
United Kingdom Market for microRNA (miRNA): Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
microRNA (miRNA) Market in the United Kingdom: Historic Sales Analysis in US$ by Type for the Period 2012-2019
United Kingdom microRNA (miRNA) Market Share Analysis by Type: 2012 VS 2020 VS 2027
United Kingdom Demand Estimates and Forecasts for microRNA (miRNA) in US$ by Application: 2020 to 2027
United Kingdom microRNA (miRNA) Market in US$ by Application: 2012-2019
microRNA (miRNA) Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
United Kingdom Demand Estimates and Forecasts for microRNA (miRNA) in US$ by End-Use: 2020 to 2027
United Kingdom microRNA (miRNA) Market in US$ by End-Use: 2012-2019
microRNA (miRNA) Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Rest of Europe microRNA (miRNA) Market Estimates and Forecasts in US$ by Type: 2020-2027
microRNA (miRNA) Market in Rest of Europe in US$ by Type: A Historic Review for the Period 2012-2019
Rest of Europe microRNA (miRNA) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Rest of Europe microRNA (miRNA) Addressable Market Opportunity in US$ by Application: 2020-2027
microRNA (miRNA) Market in Rest of Europe: Summarization of Historic Demand in US$ by Application for the Period 2012-2019
Rest of Europe microRNA (miRNA) Market Share Analysis by Application: 2012 VS 2020 VS 2027
Rest of Europe microRNA (miRNA) Addressable Market Opportunity in US$ by End-Use: 2020-2027
microRNA (miRNA) Market in Rest of Europe: Summarization of Historic Demand in US$ by End-Use for the Period 2012-2019
Rest of Europe microRNA (miRNA) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
microRNA (miRNA) Market in Asia-Pacific by Type: Estimates and Projections in US$ for the Period 2020-2027
Asia-Pacific microRNA (miRNA) Historic Market Scenario in US$ by Type: 2012-2019
Asia-Pacific microRNA (miRNA) Market Share Analysis by Type: 2012 VS 2020 VS 2027
microRNA (miRNA) Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2020-2027
Asia-Pacific microRNA (miRNA) Historic Market Review in US$ by Application: 2012-2019
Asia-Pacific microRNA (miRNA) Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
microRNA (miRNA) Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027
Asia-Pacific microRNA (miRNA) Historic Market Review in US$ by End-Use: 2012-2019
Asia-Pacific microRNA (miRNA) Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
REST OF WORLD
Rest of World microRNA (miRNA) Market Estimates and Forecasts in US$ by Type: 2020 to 2027
Rest of World microRNA (miRNA) Historic Market Review by Type in US$: 2012-2019
microRNA (miRNA) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
Rest of World microRNA (miRNA) Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
microRNA (miRNA) Market in Rest of World: Summarization of Historic Demand Patterns in US$ by Application for 2012-2019
Rest of World microRNA (miRNA) Market Share Analysis by Application: 2012 VS 2020 VS 2027
Rest of World microRNA (miRNA) Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
microRNA (miRNA) Market in Rest of World: Summarization of Historic Demand Patterns in US$ by End-Use for 2012-2019
Rest of World microRNA (miRNA) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Total Companies Profiled : 20

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

General queries: Info411@StrategyR.com